Mega Lifesciences Public Company Limited logo

Mega Lifesciences Public Company Limited (MEGA)

Market Closed
15 Dec, 23:30
SET SET
฿
33. 00
-0.75
-2.22%
฿
35.96B Market Cap
18.01 P/E Ratio
1.6% Div Yield
730,189 Volume
2.72 Eps
฿ 33.75
Previous Close
Day Range
32.75 33.75
Year Range
24.3 35.5
Want to track MEGA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 69 days

Summary

MEGA closed today lower at ฿33, a decrease of 2.22% from yesterday's close, completing a monthly decrease of -0.75% or ฿0.25. Over the past 12 months, MEGA stock lost -0.75%.
MEGA pays dividends to its shareholders, with the most recent payment made on Sep 12, 2025. The next estimated payment will be in In 2 months on Mar 12, 2026 for a total of ฿0.8.
The last earnings report, released on Nov 13, 2025, exceeded the consensus estimates by 0.04%. On average, the company has fell short of earnings expectations by -0.04%, based on the last three reports. The next scheduled earnings report is due on Feb 23, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on SET (THB).

MEGA Chart

Similar

Home Product Center Public Company Limited
฿ 6.4
+0.79%
Siam Global House Public Company Limited
฿ 6.3
+1.61%
Com7 Public Company Limited
฿ 20.8
+1.46%
TOA
Toa Paint (Thailand) Public Company Limited
฿ 13.8
+2.22%
SISB Public Company Limited
฿ 12.2
+2.52%

Mega Lifesciences Public Company Limited (MEGA) FAQ

What is the stock price today?

The current price is ฿33.00.

On which exchange is it traded?

Mega Lifesciences Public Company Limited is listed on SET.

What is its stock symbol?

The ticker symbol is MEGA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.6%.

What is its market cap?

As of today, the market cap is 35.96B.

When is the next earnings date?

The next earnings report will release on Feb 23, 2026.

Has Mega Lifesciences Public Company Limited ever had a stock split?

No, there has never been a stock split.

Mega Lifesciences Public Company Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Vivek Dhawan CEO
SET Exchange
TH4984010009 ISIN
TH Country
- Employees
27 Aug 2025 Last Dividend
- Last Split
- IPO Date

Overview

Mega Lifesciences Public Company Limited, established in 1982 and based in Bangkok, Thailand, operates in the health and wellness sector. The company, through its subsidiaries, engages in the manufacturing and sale of a wide range of health-related products including health food supplements, prescription pharmaceutical products, over-the-counter (OTC) items, herbal products, vitamins, and fast-moving consumer goods, primarily focusing on markets in Southeast Asia and Sub-Saharan Africa. Mega Lifesciences operates under three main business segments: Brands, Distribution, and Original Equipment Manufacture (OEM). A notable subsidiary of Unistretch Limited, the company also extends its services to logistical support and marketing for third-party products and has ventured into software design and development services.

Products and Services

  • Medicines & Supplements

    The company offers a comprehensive range of medicines and supplements targeting various health concerns. These include allergies, blood circulation and memory enhancement, bone and joint care, liver and digestive health, eye, heart, and skin care, pain relief, sleep aids, general well-being, herbal remedies, cough, and cold remedies, as well as an assortment of vitamins, probiotics, medical, and sports nutrition products. Special care categories also cater to kids', men's, and women's health needs, ensuring a holistic approach to family well-being.

  • Prescription Medicines

    Mega Lifesciences provides an extensive portfolio of prescription medicines across a wide range of therapeutic areas. These areas include, but are not limited to, anti-allergic, anti-infective, treatments for the central nervous system, cardiovascular system, dermatology, diabetes management, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedics, pain management, respiratory care, rheumatology, and urology. This wide range ensures the company's presence in critical areas of healthcare and medical treatment.

  • Distribution and Logistical Services

    Aside from its own product offerings, the company provides vital logistical and marketing services for goods manufactured by third parties. These services are designed to support the efficient distribution and sale of a variety of healthcare products, facilitating access to essential medicines and supplements across its operating regions.

  • Software Design and Development Services

    In a diversification of its portfolio, Mega Lifesciences has also ventured into the technology sector, engaging in software design, development, and other related services. This expansion reflects the company's commitment to innovation and its recognition of the growing importance of technology in enhancing health services delivery.

Contact Information

Address: 909, Ample Tower, Bangkok, Thailand, 10260
Phone: 66 2 769 4222